🔎 Trials Near Me

Akèy › Kansè Metastatik › Lwizyàn › New Orleans

Etid klinik pou Kansè Metastatik nan New Orleans, LA

9 etid pou Kansè Metastatik ap chèche patisipan nan sit nan ak bò kote New Orleans (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial

Ap rekriteFaz 2
  • Ochsner Medical Center Jefferson, New Orleans
Tout laj · Tout sèks · Mizajou Oct 5, 2026 · NCT05564377

A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer

Ap rekriteFaz 3
  • Ochsner Clinic Foundation, New Orleans
Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT07213804

A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract

Ap rekriteFaz 3
  • Ochsner Clinic Foundation, New Orleans
Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT07218380

Personalized Antibody-Drug Conjugate Therapy Based on RNA and Protein Testing for the Treatment of Advanced or Metastatic Solid Tumors (The ADC MATCH Screening and Treatment Trial)

Ap rekriteFaz 2
  • Ochsner Medical Center Jefferson, New Orleans
Laj 18 ak plis · Tout sèks · Mizajou Sep 4, 2026 · NCT06311214

Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.

Ap rekriteFaz 3
  • Care Access-Marrero, Marrero · 4 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Sep 2, 2026 · NCT06072612

FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3

Ap rekriteFaz 1
  • Ochsner Clinic Foundation, New Orleans
Laj 18 ak plis · Tout sèks · Mizajou Aug 20, 2026 · NCT05614739

A Study of CHS-114 (Tagmokitug) in Combination With Toripalimab and/or Other Treatments in Participants With Advanced Solid Tumors

Ap rekriteFaz 1
  • Ochsner Health, New Orleans
Laj 18 ak plis · Tout sèks · Mizajou Jul 15, 2026 · NCT06657144

Evaluation of RBS2418 in Subjects With Advanced, Metastatic Solid Tumors

Ap rekriteFaz 1
  • Ochsner Clinic Foundation, New Orleans
Laj 18 ak plis · Tout sèks · Mizajou Dec 19, 2025 · NCT05270213

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Ap rekriteEtid obsèvasyon
  • Massive Bio SYNERGY-AI site, New Orleans
Tout laj · Tout sèks · Mizajou Oct 28, 2025 · NCT03452774

Etid Kansè Metastatik nan lòt vil

Lòt etid nan New Orleans

Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.